Treatment of carcinoma of unknown primary site (CUP) directed by molecular profiling diagnosis: A prospective, phase II trial.John D. Hainsworth, F. Anthony Greco, E. P. Fox et al.|Journal of Clinical Oncology|2010Cited by 11
Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients (pts) with carcinoma of unknown primary site (CUP): Results of a prospective Sarah Cannon Research Institute (SCRI) trial.Frank A. Greco, John D. Hainsworth, Mark S. Rubin et al.|Journal of Clinical Oncology|2012Cited by 4